NABRIVA THERAPEUTICS PLC's ticker is and the CUSIP is G63637105. A total of 49 filers reported holding NABRIVA THERAPEUTICS PLC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $5,249,000 | -61.0% | 3,594,568 | -27.9% | 0.00% | -66.7% |
| Q3 2018 | $13,459,000 | -24.0% | 4,984,746 | -2.0% | 0.00% | -25.0% |
| Q2 2018 | $17,707,000 | -31.5% | 5,088,441 | -1.0% | 0.00% | -33.3% |
| Q1 2018 | $25,856,000 | +148.7% | 5,140,289 | +195.6% | 0.01% | +200.0% |
| Q4 2017 | $10,397,000 | -31.7% | 1,738,696 | -6.4% | 0.00% | -33.3% |
| Q3 2017 | $15,218,000 | -37.0% | 1,858,113 | -13.7% | 0.00% | -50.0% |
| Q2 2017 | $24,169,000 | – | 2,152,151 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vivo Capital, LLC | 4,074,190 | $33,368,000 | 6.74% |
| Novo Holdings A/S | 2,903,800 | $23,782,000 | 3.10% |
| PURA VIDA INVESTMENTS, LLC | 425,000 | $3,481,000 | 1.02% |
| ACUTA CAPITAL PARTNERS, LLC | 400,000 | $3,276,000 | 0.59% |
| Monashee Investment Management LLC | 188,000 | $1,540,000 | 0.58% |
| Orbimed Advisors | 3,919,600 | $32,102,000 | 0.31% |
| FT Options LLC | 20,000 | $164,000 | 0.25% |
| Rock Springs Capital Management LP | 625,000 | $5,119,000 | 0.24% |
| Rubric Capital Management LP | 300,000 | $2,457,000 | 0.22% |
| Ghost Tree Capital, LLC | 120,000 | $983,000 | 0.21% |